Sort
40,608 grants matching “prostate cancer”
Time-resolved FRET-based allostery sensors for any protein kinase drug target
$370,320Nicholas Mark Levinson · University Of Minnesota · R33 · FY2022 · CA
Project 4: Targeting Genomic Instability in Distinct Subclasses of Prostate Cancer
$370,291Christopher E Barbieri · Weill Medical Coll Of Cornell Univ · P50 · FY2018 · CA
P13K/PTEN/Akt signaling and the genesis of cancer
$370,234Nissim Hay · University Of Illinois At Chicago · R01 · FY2010 · CA
Project 3: Molecular basis for epigenome homeostasis by histone chaperone and acetyltransferase complexes
$370,232Ronen Marmorstein · University Of Pennsylvania · P01 · FY2022 · AG
Community Outreach and Engagement
$370,230Lourdes Baezconde Garbanati · University Of Southern California · P30 · FY2024 · CA
Role of PALB2 in the DNA Damage Response and Cancer Suppression
$370,173Bing Xia · Rutgers Biomedical And Health Sciences · R01 · FY2024 · CA
Daily Quantification of Cancer-Associated Exosomal miRNA in Patient Blood by Photonic Crystal-Enhanced Quantum Dot Emission
$370,139Andrew Michael Smith · University Of Illinois At Urbana-Champaign · R01 · FY2019 · CA
Role of Caveolin-1 in the Maintenance of Blood-retinal Barrier Integrity
$370,115Michael H Elliott · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2021 · EY
TUMOR-TARGETED RADIOSENSITIZERS IN CANCER THERAPY
$370,108Florida Biotechnology, Inc. · R44 · FY2001 · CA
Sympathetic modulation of head and neck cancer pain
$370,073Nicole N Scheff · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · DE
Leveraging the methionine salvage pathway as a novel therapy for prostate cancer.
$370,063Dominic James Smiraglia · Roswell Park Cancer Institute Corp · R01 · FY2019 · CA
Interleukin-1beta and AR-negative tumor cells in metastatic castrate-resistant prostate cancer
$370,047Alessandro Fatatis · Drexel University · R01 · FY2024 · CA
Vitamin D in Prostate Cancer: Tumor Vasculature Effects
$370,027Roswell Park Cancer Institute Corp · R01 · FY2003 · CA
Mechanisms of cancer cell chemotaxis in perineural invasion
$370,007Richard J Wong · Sloan-Kettering Inst Can Research · R01 · FY2011 · CA
Control of Apoptosis in Cancer by Survivin
$370,000Dario C. Altieri · Wistar Institute · R01 · FY2014 · CA
Control of Apoptosis in Cancer by Survivin
$370,000Dario C. Altieri · Wistar Institute · R01 · FY2015 · CA
Project-1: Defining the mechanisms by which neurons promote breast cancer metastasis
$369,983Sohail F. Tavazoie · Rockefeller University · U54 · FY2025 · CA
Gut bacterial metabolism of the side-chain of corticosteroids
$369,955Jason Michael Ridlon · University Of Illinois At Urbana-Champaign · R01 · FY2022 · GM
Daily Quantification of Cancer-Associated Exosomal miRNA in Patient Blood by Photonic Crystal-Enhanced Quantum Dot Emission
$369,941Andrew Michael Smith · University Of Illinois At Urbana-Champaign · R01 · FY2021 · CA
Comprehensive genetic dissection of druggable KRAS targets
$369,932Steven D Leach · Dartmouth College · R01 · FY2019 · CA
A New Mechanism for Castration Resistant Prostate Cancer
$369,879Zijie Sun · Stanford University · U01 · FY2013 · CA
P63 IN EPITHELIAL CELL PROLIFERATION AND DIFFERENTIATION
$369,873Harvard University (Medical School) · R01 · FY2000 · CA
Intercellular Transfer of Mitochondria at the Nerve-Cancer Interface
$369,868Simon Grelet · University Of South Alabama · R37 · FY2025 · CA
Targeting a Novel Epigenetic Signaling Nexus ACK1-pY88H4-AR/AR-V7 in Drug Resistant Metastatic Prostate Cancer
$369,843Nupam P Mahajan · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2017 · CA
Targeting a Novel Epigenetic Signaling Nexus ACK1-pY88H4-AR/AR-V7 in Drug Resistant Metastatic Prostate Cancer
$369,843Nupam P Mahajan · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2018 · CA